Abstract
Renal failure is defined as the cessation of kidney function. Acute renal failure (ARF) involves the failure of the kidney over a period of hours or days and is potentially reversible, whereas chronic renal failure (CRF) develops over months or years and involves the irreversible destruction of kidney tissue by progressive renal disease(s) leading to endstage renal disease (ESRD).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Thadhani, R., Pascual, M., and Bonventre, J. V. (1996) Acute renal failure. N. Engl. J. Med. 334, 1448–1460.
Star, R. A. (1998) Treatment of acute renal failure. Kidney Int. 54, 1817–1831.
McCarthy, J. T. (1996) Prognosis of patients with acute renal failure in the intensive care unit: a tail of two eras. Mayo Clinic Proc. 71, 117–126.
Breen, D. and Bihari, D. (1998) Acute renal failure as a part of multiple organ failure: the slippery slope of critical illness. Kidney Int. 66, S25–S33.
Maisonneuve, P., Agodoa, L., Gellert, R., Stewart, J. H., Buccianti, G., Lowenfels, A. B., et al. (2000) Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am. J. Kidney Dis. 35, 157–165.
Ritz, E., Rychlik, I., Locatelli, F., and Halimi, S. (1999) End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am. J. Kidney Dis. 34, 795–808.
U.S. Renal Data System (USRDS) at http://www.usrds.org
Gilbert, R. E., Kelly, D. J., and Atkins, R. C. (2001) Novel approaches to the treatment of progressive renal disease. Curr. Opin. Pharmacol. 1, 183–189.
Bakris, G. L., Williams, M., Dworkin, L., Elliott, W. J., Epstein, M., Toto, R., et al. (2000) Preserving renal function in adults with hypertension and diabetes: a concensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working group. Am. J. Kidney Dis. 36, 646–661.
Lewis E. J., Hunsicker L. G., Bain, R. P., and Rohde, R. D. (1993) The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The collaborative study group. N. Engl. J. Med. 329, 1456–1462.
The GISEN group (Gruppo Italiano di Studi Epidemiologici in Nephrologia). (1997) Randomized placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349, 1857–1863.
Goekjian, P. G. and Jirousek, M. R. (1999) Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr. Med. Chem. 6, 877–903.
Koya, D., Haneda, M., Nakagawa, H., Isshiki, K., Sato, H., Maeda, S., et al. (2000) Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J. 14, 439–447.
Eckardt, K. U. (2000) Acute renal failure—more than kidney ischemia? Wein. Klin. Wochenschr. 112, 145–148.
Kaysen, G. A. (2000) Inflammation and oxidative stress in end-stage renal disease. Adv. Nephrol. Necker Hosp. 30, 201–214.
Vos, I. H., Rabelink, T. J., Dorland, B., Loos, R., Van Middelaar, B., Grone, H. J. et al. (2001) L-arginine supplementation improves function and reduces inflammation in renal allografts. J. Am. Soc. Nephrol. 12, 361–367.
Albrecht, E. W., van Goor, H., Tiebosch, A. T., Moshage, H., Tegzess, A. M., and Stegeman, C. A. (2000) Nitric oxide production and nitric oxide synthase expression in acute human renal allograft rejection. Transplantation 70, 1610–1616.
Couser, W. G. (1998) Pathogenesis of glomerular damage in glomerulonephritis. Nephrol. Dial. Transplant. 13, 10–15.
van Kooten, C., Langers, A. M., Bruijn, J. A., and Daha, M. R. (1999) Role of tubular cells in progressive renal disease. Kidney Blood Press. Res. 22, 53–61.
Daha, M. R. and van Kooten, C. (2000) Is the proximal tubular cell a proinflammatory cell? Nephrol. Dial. Transplant. 15, 41–43.
Inthorn, D. and Hoffman, J. N. (1996) Elimination of inflammatory mediators by hemofiltration. Int. J. Artif. Organs 19, 124–126.
Montoliu, J. (1997) Clearance of inflammatory mediators through continuous renal replacement therapy. Blood Purif. 15, 305–308.
Molitoris, B. A. and Marrs, J. (1999) The role of cell adhesion molecules in ischemic acute renal failure. Am. J. Med. 106, 583–592.
Lieberthal, W. (1998) Biology of ischemic and toxic renal tubular cell injury: role of nitric oxide and the inflammatory response. Curr. Opin. Nephrol. Hypertens. 7, 289–295.
Baud, L. and Ardaillou, R. (1986) Reactive oxygen species: production and role in the kidney. Am. J. Physiol. 251, F765–F776.
Guijarro, C. and Egido, J. (2001) Transcription factor-ºB (NF-ºB) and renal disease. Kidney Int. 59, 415–424.
Grace, P. A. (1994) Ischaemia-reperfusion injury. Br. J. Surg. 81, 637–647.
Weight, S. C., Furness, P. N., and Nicholson, M. L. (1998) Nitric oxide generation is increased in experimental renal warm ischemia-reperfusion injury. Br. J. Surg. 85, 1663–1668.
Nath K. A. and Norby, S. M. (2000) Reactive oxygen species and acute renal failure. Am. J. Med. 109, 665–678.
Pryor, W. and Squadrito, G. (1995) The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268, L699–L772.
Wei, X. Q., Charles, I. G., Smith, A., Ure, J., Feng, G. J., Huang, F. P., et al. (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408–411.
Chatterjee P. K., Cuzzocrea, S., Brown, P. A., Zacharowski, K., Stewart, K. N., Mota-Filipe, H., et al. (2000) Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int. 58, 658–673.
Klahr, S. (2001) The role of nitric oxide in hypertension and renal disease progression. Nephrol. Dial. Transplant. 16, 60–62.
Weight, S. C., Bell, P. R., and Nicholson, M. L. (1996) Renal ischemia-reperfusion injury. Br. J. Surg. 83, 162–170.
Novis, B. K., Roizen, M. F., Aronson, S., and Thisted, R. A. (1994) Association of preoperative risk factors with postoperative acute renal failure. Anesth. Analg. 778, 143–149.
Aronson, S. and Blumenthal, R. (1998) Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J. Cardiothorac. Vasc. Anesth. 17, 117–130.
Paller, M. S. (1994) The cell biology of reperfusion injury in the kidney. J. Investig. Med. 42, 632–639.
Shoskes, D. A. and Halloran, P. F. (1996) Delayed graft function in renal transplantation: etiology, management and long-term significance. J. Urol. 155, 1837–1840.
Chatterjee, P. K., Brown, P. A. J., Cuzzocrea, S., Zacharowski, K., Stewart, K. N., Mota-Filipe, H., et al. (2001) Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int. 59, 2073–2083.
Singbartl, K., Green, S. A., and Ley, K. (2000) Blocking P-selectin protects from ischemia/reperfusion-induced acute renal failure. FASEB J. 14, 48–54.
Chatterjee, P. K., Zacharowski, K., Cuzzocrea, S., Otto, M., and Thiemermann, C. (2000) Inhibitors of poly (ADP-ribose) synthetase reduce ischemia-reperfusion injury in the anesthetised rat in vivo. FASEB J. 14, 641–651.
Chatterjee, P. K., Hawksworth, G. M., and McLay, J. S. (1999) Cytokine-stimulated nitric oxide production in human renal proximal tubule and its modulation by natriuretic peptides: a novel immunomodulatory mechanism? Exp. Nephrol. 7 438–448.
Chatterjee, P.K., Cuzzocrea, S., and Thiemermann, C. (1999) Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress. Kidney Int. 56, 973–984.
Williams, P., Lopez, H., Britt, D., Chan, C., Ezrin, A., and Hottendorf, R. (1997) Characterisation of renal ischemia-reperfusion injury in rats. J. Pharm. Toxicol. Meth. 37, 1–7.
Zager, R. A. and Altschuld, R. (1986) Body temperature: an important determinant of severity of ischemic renal injury. Am. J. Physiol. 251, F87–F93.
Zager, R. A., Gmur, D. J., Bredl, C. R., and Eng, M. J. (1991) Temperature effects on ischemic and hypoxic renal proximal tubular injury. Lab. Invest. 64, 766–776.
Baum, N., Dichoso, C. C., and Carlton, C. E. (1975) Blood urea nitrogen and serum creatinine: physiology and interpretations. Urology 5, 583–588.
Stogdale, L. (1981) Correlation of changes in blood chemistry with pathological changes in the animal’s body: II Electrolytes, kidney function tests, serum enzymes, and liver function tests. J. South Afr. Vet. Assoc. 52, 155–164.
Harrison, D. J., Kharbanda, R., Scott-Cunningham, D., McLellan, L. I., and Hayes, J. D. (1989) Distribution of glutathione S-transferase isoenzymes in human kidney: basis for possible markers of renal injury. J. Clin. Pathol. 42, 624–628.
Bosomworth, M. P., Aparicio, S. R. and Hay, A. W. M. (1999) Urine N-acetyl-β-d-glucosaminidase—a marker of tubular damage? Nephrol. Dial. Transplant. 14, 620–626.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Chatterjee, P.K., Thiemermann, C. (2003). An In Vivo Model of Ischemia/Reperfusion and Inflammation of the Kidneys of the Rat. In: Winyard, P.G., Willoughby, D.A. (eds) Inflammation Protocols. Methods in Molecular Biology, vol 225. Humana Press. https://doi.org/10.1385/1-59259-374-7:223
Download citation
DOI: https://doi.org/10.1385/1-59259-374-7:223
Publisher Name: Humana Press
Print ISBN: 978-0-89603-970-4
Online ISBN: 978-1-59259-374-3
eBook Packages: Springer Protocols